Metronomic Chemotherapy in Breast Cancer:Unleashing the Potential of Combination RegimensOA
Metronomic Chemotherapy in Breast Cancer:Unleashing the Potential of Combination Regimens
Jiaxuan Liu;Hongnan Mo;Qiao Li;Marina Elena Cazzaniga;Fei Ma
Department of Medical Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaDepartment of Medical Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaDepartment of Medical Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaDepartment of Medicine and Surgery,University of Milano-Bicocca,Monza,ItalyPhase 1 Unit,Fondazione IRCCS San Gerardo dei Tintori,Monza,Italy
angiogenesis inhibitorsantineoplastic combined chemotherapy protocolsbreast neoplasmsimmunotherapymetronomic chemotherapytumor microenvironment
angiogenesis inhibitorsantineoplastic combined chemotherapy protocolsbreast neoplasmsimmunotherapymetronomic chemotherapytumor microenvironment
《肿瘤学创新（英文）》 2025 (6)
51-65,15
This study was funded by National Key Research and Development Program of China(Grant number 2024YFA1107400).
评论